Rhenman & Partners Asset Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-36,667
| Closed | -$1.24M | – | 92 |
|
2022
Q4 | $1.24M | Hold |
36,667
| – | – | 0.13% | 89 |
|
2022
Q3 | $2.07M | Hold |
36,667
| – | – | 0.22% | 84 |
|
2022
Q2 | $2.09M | Sell |
36,667
-4,259
| -10% | -$243K | 0.24% | 78 |
|
2022
Q1 | $3.31M | Sell |
40,926
-22,407
| -35% | -$1.81M | 0.33% | 75 |
|
2021
Q4 | $13.3M | Hold |
63,333
| – | – | 0.88% | 42 |
|
2021
Q3 | $17.1M | Hold |
63,333
| – | – | 1.2% | 39 |
|
2021
Q2 | $16.3M | Sell |
63,333
-23,813
| -27% | -$6.13M | 1.11% | 39 |
|
2021
Q1 | $26.1M | Sell |
87,146
-2,854
| -3% | -$856K | 1.82% | 17 |
|
2020
Q4 | $23M | Buy |
90,000
+23,333
| +35% | +$5.95M | 1.87% | 16 |
|
2020
Q3 | $16.6M | Buy |
66,667
+14,000
| +27% | +$3.48M | 1.48% | 29 |
|
2020
Q2 | $18.3M | Sell |
52,667
-19,000
| -27% | -$6.6M | 1.98% | 13 |
|
2020
Q1 | $19.2M | Sell |
71,667
-1,666
| -2% | -$446K | 2.69% | 7 |
|
2019
Q4 | $23.7M | Sell |
73,333
-6,667
| -8% | -$2.16M | 2.6% | 6 |
|
2019
Q3 | $21.9M | Buy |
80,000
+31,667
| +66% | +$8.65M | 2.74% | 6 |
|
2019
Q2 | $25.8M | Sell |
48,333
-630
| -1% | -$336K | 2.84% | 6 |
|
2019
Q1 | $24.7M | Buy |
48,963
+14,630
| +43% | +$7.37M | 2.89% | 7 |
|
2018
Q4 | $16.9M | Buy |
34,333
+13,973
| +69% | +$6.89M | 1.94% | 19 |
|
2018
Q3 | $18.6M | Sell |
20,360
-20,817
| -51% | -$19M | 1.87% | 19 |
|
2018
Q2 | $30.2M | Buy |
41,177
+27,346
| +198% | +$20M | 3.09% | 1 |
|
2018
Q1 | $22M | Sell |
13,831
-9,736
| -41% | -$15.5M | 2.72% | 8 |
|
2017
Q4 | $21.1M | Sell |
23,567
-34,179
| -59% | -$30.6M | 2.85% | 6 |
|
2017
Q3 | $20.8M | Buy |
57,746
+4,746
| +9% | +$1.71M | 2.65% | 8 |
|
2017
Q2 | $15.5M | Buy |
53,000
+21,667
| +69% | +$6.35M | 2.23% | 12 |
|
2017
Q1 | $11M | Buy |
31,333
+4,000
| +15% | +$1.41M | 1.75% | 19 |
|
2016
Q4 | $5.03M | Buy |
27,333
+1,333
| +5% | +$245K | 0.96% | 40 |
|
2016
Q3 | $6.7M | Sell |
26,000
-5,333
| -17% | -$1.37M | 1.06% | 34 |
|
2016
Q2 | $6.69M | Sell |
31,333
-3,667
| -10% | -$783K | 1.19% | 28 |
|
2016
Q1 | $7.22M | Sell |
35,000
-3,733
| -10% | -$770K | 1.43% | 31 |
|
2015
Q4 | $9.79M | Sell |
38,733
-7,134
| -16% | -$1.8M | 1.48% | 30 |
|
2015
Q3 | $7.54M | Sell |
45,867
-16,600
| -27% | -$2.73M | 1.2% | 35 |
|
2015
Q2 | $11.7M | Sell |
62,467
-3,973
| -6% | -$746K | 1.41% | 18 |
|
2015
Q1 | $11M | Buy |
66,440
+50,573
| +319% | +$8.34M | 1.85% | 16 |
|
2014
Q4 | $3.69M | Sell |
15,867
-18,000
| -53% | -$4.18M | 1.07% | 31 |
|
2014
Q3 | $6.13M | Buy |
33,867
+16,534
| +95% | +$2.99M | 1.8% | 12 |
|
2014
Q2 | $3.33M | Buy |
17,333
+5,213
| +43% | +$1M | 0.99% | 32 |
|
2014
Q1 | $2.2M | Sell |
12,120
-547
| -4% | -$99.4K | 0.66% | 54 |
|
2013
Q4 | $2.16M | Buy |
+12,667
| New | +$2.16M | 0.84% | 51 |
|